Skip to main content
 
 

IDEASThe cycle appears to be turning

As we move closer to the halfway mark for CY24, the U.S. economy has displayed remarkable resilience, with stocks at near all-time highs and the S&P 500 defying forecasts for a slowdown.

 
 

EQUITIESClinuvel Pharmaceuticals

CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with vitiligo.

 
 

EQUITIESSeven Group

With the Boral acquisition nearing completion, we revisit our SVW model forecasts.

 
 

ADMINISTRATIONPortfolio Administration Service

Bell Potter can take the hard work out of administering your investments with our Portfolio Administration Service (PAS).

 
 

EQUITIESInternational Shares

We can assist you invest directly in equity markets in the US, Japan, Europe and the UK, as well as other major exchanges around the globe.

At Bell Potter, we bring together people, ideas and capital to serve the needs of our clients.

HOW CAN WE HELP YOU?

As a leading full service Australian stockbroking and financial advisory firm, we provide a comprehensive range of services for our clients.

Personal

  • Australian Stockbroking
  • International Stockbroking
  • Fixed Income
  • Portfolio Administration
  • Technical Financial Advice
  • Superannuation
  • Foreign Exchange
  • Lending
  • At-Call Facilities

Go to section

Corporates

  • Placements
  • Market sell-downs & block trades
  • Equity Capital raisings
  • IPOs
  • Corporate Advice & Structuring
  • Share Price Advice & Valuation
  • Mergers & Acquisition Advice & Execution

Go to section

Institutions

  • Sales
  • Trading
  • Research
  • Corporate Access

Go to section

Research

  • Equities
  • Strategy
  • Hybrid & Fixed income
  • LICs & ETFs
  • Currency
  • Commodities

Go to section

Advisers

  • General advice
  • Execution, Clearing & Settlement
  • Stock market advisory services
  • Research
  • Corporate opportunities
  • mFunds

Go to section

Quality advice starts with a conversation

Speak with an experienced adviser today.

REQUEST A CALLBACK

IDEAS AND RESEARCH

Clinuvel Pharmaceuticals (CUV): Looking to Vitiligo

| Equities, Industrials | No Comments
CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with vitiligo.

Seven Group Holdings (SVW): Rounding out the portfolio

| Equities, Resources | No Comments
With the Boral (BLD) acquisition nearing completion, we revisit our SVW model forecasts.

The cycle appears to be turning

| Equities, International | No Comments
As we move closer to the halfway mark for CY24, the U.S. economy has displayed remarkable resilience, with stocks at near all-time highs and the S&P 500 defying forecasts for a slowdown.
MORE IDEAS

ABOUT US

Bell Potter is a member of the Bell Financial Group (BFG.ASX) of companies. We are one of Australia’s leading full service Australian stockbroking and financial advisory firms, offering a full range of services to private, corporate and institutional clients.

Find out more